SAN DIEGO, April 09, 2018 -- TheRecover.com defines three of the most common drug rehabilitation processes.
|
|||||
Biophysical Drug Treatment
This is the most effective type of treatment available, producing some of the highest success rates possible. Biophysical addiction treatment centers utilize a holistic body cleansing process that purges unwanted drug residue from the body's fatty tissue. This is usually a long-term treatment program (90 days or more) which contains an educational process (non 12 step rehab) to aid in life management skills. These two properly balanced drug rehabilitation process have been an extremely successful combination compared to other programs.
12 Step Drug Treatment
12 step rehab counseling was founded in the mid 1930s and over the years has become one of the most widely used methods of addiction treatment. While it has worked for some, there has been growing opposition and shift away from this treatment method. Most 12 step drug rehab programs consist largely of only group counseling and the belief that addiction is an incurable brain disease with relapse being inevitable. Other methods of treatment have a much more conducive philosophy to the proper regimen and eradication of addiction.
Medical Detox Treatment
A medical detox program is just a supervised gradient step-down or tapering process. Medical detox facilities are typically only necessary when there are severe risks of withdrawing from the drug. Once completed, it is recommended to follow up with a treatment program that gets to the root of what started the addiction in the first place, and gives the person the stability needed to not relapse. A biophysical drug rehab treatment program goes far beyond simple withdrawal, removing the remaining drug residues that would otherwise be left in the body.
Contact Info:
Author: Kevin Leonard
Organization: TheRecover.com
Address: 27420 Jefferson Ave, Temecula, CA 92590
Phone: 888-325-2454
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/50cbdc89-ac7f-4bab-a901-2f65a6575d5d


FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Samsung Electronics Shares Jump on HBM4 Mass Production Report
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 



